An Enhanced Hybrid Screening Approach to Identify Potent Inhibitors for the SARS-CoV-2 Main Protease From the NCI Compound Library.

Li, Shuhua G; Yang, Kai S; Blankenship, Lauren R; Cho, Chia-Chuan D; Xu, Shiqing; Wang, Hongbin; Liu, Wenshe Ray

Li, Shuhua G; Yang, Kai S; Blankenship, Lauren R; Cho, Chia-Chuan D; Xu, Shiqing; Wang, Hongbin; Liu, Wenshe Ray.

Afiliação

Li SG; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, United States.
Yang KS; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, United States.
Blankenship LR; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, United States.
Cho CD; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, United States.
Xu S; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, United States.
Wang H; Center for Biomedical Informatics, College of Medicine, Texas A&M University, Houston, TX, United States.
Liu WR; Texas A&M Drug Discovery Laboratory, Department of Chemistry, Texas A&M University, College Station, TX, United States.

Front Chem ; 10: 816576, 2022.

Article em En | MEDLINE | ID: mdl-35252116

Palavras-chave

COVID-19; SAR-CoV-2; main protease; statistical analysis; virtual screening

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Front Chem Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google